Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis

Blood

Volumn 104, Issue 5, 2004, Pages 1519-1525

  Chua, Anita C G ^b   Olynyk, John K ^b   Leedman, Peter J ^b   Trinder, Debbie ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,2' BIPYRIDINE; BATHOPHENANTHROLINE DISULFONATE; DIFERRIC TRANSFERIN; FERRIC CITRATE; FERROUS ION; HFE PROTEIN; IRON; IRON CHELATE; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NONTRANSFERRIN BOUND IRON; PHENANTHROLINE DERIVATIVE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE ACTIVITY; GENE MUTATION; HEMOCHROMATOSIS; IRON BLOOD LEVEL; IRON OVERLOAD; IRON TRANSPORT; KNOCKOUT MOUSE; LIVER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 4444226451     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-11-3872     Document Type: Article

References (47)

1. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341:718-724.
2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
3. Olynyk JK. Hereditary haemochromatosis: diagnosis and management in the gene era. Liver. 1999;19:73-80.
4. Olynyk JK, Bacon BR. Hereditary hemochromatosis: detecting and correcting iron overload. Postgrad Med. 1994;96:151-165.
5. Trinder D, Morgan EH. Uptake of transferrin-bound iron by mammalian cells. In: Templeton DM, ed. Molecular and Cellular Iron Transport. New York, NY: Marcel Dekker Inc; 2002:427-450.
6. Baker E, Baker SM, Morgan EH. Characterisation of non-transferrin-bound iron (ferric citrate) uptake by rat hepatocytes in culture. Biochim Biophys Acta. 1998;1380:21-30.
7. Graham RM, Morgan EH, Baker E. Characterization of citrate and iron citrate uptake by cultured rat hepatocytes. J Hepatol. 1998;29:603-613.
8. Trinder D, Morgan EH. Mechanisms of ferric citrate uptake by human hepatoma cells. Am J Physiol. 1998;275:G279-G286.
9. Sarkar B. State of iron (111) in normal human serum: low molecular weight and protein ligands besides transferrin. Can J Biochem. 1970;48:1339-1350.
10. Brissot P, Wright TL, Ma WL, Weisiger RA. Efficient clearance of non-transferrin-bound iron by rat liver: implications for hepatic iron loading in iron overload states. J Clin Invest. 1985;76:1463-1470.
11. Hershko C, Peto TEA. Non-transferrin plasma iron. Br J Haematol. 1987;66:149-151.
12. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis: characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem. 1989;264:4417-4422.
13. Graham RG, Morgan EH, Baker E. Ferric citrate uptake by cultured rat hepatocytes is inhibited in the presence of transferrin. Eur J Biochem. 1998;253:139-145.
14. Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998;95:2492-2497.
15. Fleming RE, Migas MC, Zhou XY, et al. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A. 1999;96:3143-3148.
16. Ajioka RS, Levy JE, Andrews NC, Kushner JP. Regulation of iron absorption in Hfe mutant mice. Blood. 2002;100:1465-1469.
17. Trinder D, Drake S, Lowes K, Chua ACG, Olynyk JK, Morgan EH. Effect of iron status on the absorption of iron by the Hfe knockout model of hereditary haemochromatosis [abstract]. Hepatology. 2002;36:334A. Abstract 686.
18. Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem. 1999;273:212-220.
19. Loreal O, Gosriwatana I, Guyader D, Porter J, Brissot P, Hider RC. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol. 2000;32:727-733.
20. Knight B, Yeoh GCT, Husk KL, et al. Impaired preneoptastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med. 2000;192:1809-1818.
21. Seglen PO. Preparation of rat liver cells. Exp Cell Res. 1973;82:391-398.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
23. Trinder D, Oates PS, Thomas C, Sadleir J, Morgan EH. Localisation of the divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocyes in iron overload. Gut. 2000;46:270-276.
24. Aruoma OI, Bomford A, Polson RJ, Halliwell B. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood. 1988;72:1416-1419.
25. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin- bound iron (NTBI) used for assessing iron chelation therapy. Transfus Sci. 2000;23:241-242.
26. Bacon BR, Tavill AS. Hemochromatosis and the iron overload syndromes. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. Philadelphia, PA: W.B. Saunders; 1996:1439. 1471.
27. Wright TL, Brissot P, Ma WL, Weisiger RA. Characterization of non-transferrin-bound iron clearance by rat liver. J Biol Chem. 1986;261:10909-10914.
28. Randell EW, Parkes JG, Olivieri NF, Templeton DM. Uptake of nontransferrin-bound iron by both reductive and non-reductive processes is modulated by intracellular iron. J Biol Chem. 1994;269:16046-16053.
29. Inman RS, Coughlan MM, Wessling-Resnick M. Extracellular ferrireductase activity of K562 cells is coupled to transferrin-independent iron transport. Biochem. 1994;33:11850-11857.
30. Scheiber-Mojdehkar B, Zimmermann I, Dresow B, Goldenberg H. Differential response of non-transferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron. J Hepatol. 1999;31:61-70.
31. Trinder D, Morgan EH. Inhibition of uptake of transferrin-bound iron by human hepatoma cells by nontransferrin-bound iron. Hepatol. 1997;26:691-698.
32. Lee AWM, Oates PS, Trinder D. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells. Hepatol. 2003;38:967-977.
33. Thorstensen K, Romslo I. Uptake of iron from transferrin by isolated rat hepatocytes: a redox-mediated plasma membrane process. J Biol Chem. 1988;263:8844-8850.
34. Thorstensen K, Trinder D, Zak O, Aisen P. Uptake of iron from N-terminal half-transferrin by isolated rat hepatocytes: evidence of transferrin-receptor- independent iron uptake. Eur J Biochem. 1995;232:129-133.
35. Trinder D, Fox C, Vautier G, Olynyk JK. Molecular pathogenesis of iron overload. Gut. 2002;51:290-295.
36. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388:482-488.
37. Su MA, Trenor CCIII, Fleming JC, Fleming MD, Andrews NC. The G185R mutation disrupts function of the iron transporter Nramp2. Blood. 1998;92:2157-2163.
38. Touret N, Furuya W, Forbes J, Gros P, Grinstein S. Dynamic traffic through the recycling compartment couples the metal transporter Nramp2 (DMT1) with the transferrin receptor. J Biol Chem. 2003;278:25548-25557.
39. Canonne-Hergaux F, ZhangAS, Ponka P, Gros P. Characterization of the iron transporter DMT1 (N RAM P2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood. 2001;98:3823-3830.
40. Grunheid S, Cannone-Hergaux F, Gauthier S, Hackam DJ, Grinstein S, Gros P. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med. 1999;189:831-841.
41. Muckenthaler M, Roy CN, Custodio AO, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet. 2003;34:102-107.
42. Scheiber-Mojdehkar B, Sturm B, Plank L, Kryzer I, Goldenberg H. Influence of parenteral iron preparations on non-transferrin bound iron uptake, the iron regulatory protein and the expression of ferritin and the divalent metal transporter DMT-1 in HepG2 human hepatoma cells. Biochem Pharmacol. 2003;65:1973-1978.
43. Richardson DR, Chua ACG, Baker E. Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease. J Lab Clin Med. 1999;133:144-151.
44. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98:8780-8785.
45. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A. 2002;99:4596-4601.
46. Ahmad KA, Ahmann JR, Migas MC, et al. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis. 2002;29:361-366.
47. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361:669-673.